Balyasny Asset Management LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Balyasny Asset Management LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $4.03 Million - $6.75 Million	29,100 New	29,100 $5.83 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $5.34 Million - $7.3 Million	-42,000 Reduced 42.86%	56,000 $9.14 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $11.3 Million - $14.9 Million	-71,000 Reduced 42.01%	98,000 $16.6 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $15.3 Million - $21 Million	119,000 Added 238.0%	169,000 $28.6 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $6.67 Million - $9.1 Million	-55,000 Reduced 52.38%	50,000 $7.28 Million

Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $10.9 Million - $16.4 Million	105,000 New	105,000 $15.6 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $3.73 Million - $6.21 Million	-50,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $3.55 Million - $4.39 Million	50,000 New	50,000 $4.02 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $12.2 Million - $17.1 Million	-194,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $8.18 Million - $11.5 Million	-93,500 Reduced 32.52%	194,000 $18.4 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $33.3 Million - $42.7 Million	287,500 New	287,500 $34.2 Million

584

104M

2.82M

1.75M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.